ReproSciences

12/25/2024

🌟 Season’s Greetings from the Reproductive Sciences Journal! 🌟

As we reflect on this year of discovery, innovation, and care, we celebrate the progress made toward healthier pregnancies, safer deliveries, and brighter futures for families worldwide. 🤰💡👶

Here’s to another year of advancing knowledge, supporting parents, and embracing the miracle of life! Wishing you a joyful holiday season and a hopeful New Year. 🎄✨

02/29/2024

🚨Exciting opportunity at King's College London! 🚨 Dive into groundbreaking research on Hydroxyurea's effects on pregnancy in Sickle Cell Disease. Funded by the Fetal Medicine Foundation, this project aims to improve treatment protocols & reduce complications.

🔍Study Highlights:

Examine hydroxyurea's impact using a mouse model.
Get trained in statistical analysis with R.
Engage in leadership courses & professional development.
Participate in seminars & conferences for networking.
💰Funding covers fees, living costs, & more, totaling £142,902. Open to Home Fee status candidates.

📝Apply now: Life Course Science Research MPhil/PhD. Include project title & supervisors Dr. Evangelia Vlachodimitropoulou & Dr. Panicos Shangaris. Use code "SickleCell24".

Details & apply ➡️ https://www.kcl.ac.uk/study-legacy/funding/investigating-hydroxyureas-effects-on-pregnancy-in-sickle-cell-disease

Questions?
Contact:
[email protected]

Let's tackle Sickle Cell Disease together!

This research project focuses on evaluating the safety and efficacy of hydroxyurea treatment in pregnant individuals with Sickle Cell Disease (SCD).

02/10/2024

Excited to introduce the new module "Fetal Genomics: Decoding the Blueprint of Human Development" as part of our MSc in Genomic Medicine at St George's, University of London, starting in the 2024/25 academic year. This course, offered in collaboration with King's College London at the Fetal Medicine Research Institute in Denmark Hill, features expert lectures from leaders in the field, including Professor Kypros Nicolaides.

Designed for professionals and students alike, whether pursuing an MSc, PgDip, PgCert, or seeking to enhance their skills through CPPD, this module aims to significantly boost your expertise in fetal genomics.

For NHS staff interested in advancing their education, NHSE funding may provide the support needed to explore this cutting-edge area.
Find out more about this opportunity:
https://www.sgul.ac.uk/study/courses/genomic-medicine -structure

Dive into the heart of genomic medicine in one of the most dynamic scientific communities in the world.

Genomic medicine is a rapidly evolving discipline that is already making an impact in the field of oncology, pharmacology, infectious disease and biomedical research.

12/25/2023

Wishing the esteemed readers of Reproductive Science journal a joyous Merry Christmas and a prosperous New Year! May the spirit of the season bring warmth and happiness to your lives. Here’s to a successful and fulfilling 2024 filled with groundbreaking advancements in the field of reproductive science.

12/17/2023

Tune into the 11th episode of our Reproductive Sciences Series, where host Panicos Shangaris interviews Laura Ormesher and Alice Dempsey about the CHERRY study.

Listen to this episode from Society for Reproductive Investigation on Spotify. Tune into the 11th episode of our Reproductive Sciences Series, where host Panicos Shangaris interviews Laura Ormesher and Alice Dempsey about the CHERRY study. This research explores L-citrulline supplementation in pregn...

10/12/2023

🎙️ New Podcast Episode Alert! 🎙️
I'm thrilled to announce the latest episode of Podcast 9, where I had the privilege to sit down with esteemed colleagues Elizabeth Levit, Bhuchitra Singh, Elisabeth Nylander, and James H. Segars from Johns Hopkins University School of Medicine. We delve deep into their ground-breaking paper, "A Systematic Review of Autoimmune Oophoritis Therapies," https://lnkd.in/eDN-2JGA discussing the latest advancements, potential treatments, and the road ahead for clinicians and researchers. This episode offers invaluable insights for anyone interested in autoimmune diseases, specifically focusing on oophoritis therapies. Take advantage of this enlightening conversation!
🎧 Listen now on Spotify https://lnkd.in/e8srnTN5
Feel free to like, share, and comment! Your engagement helps us bring more such knowledgeable sessions to you.

Listen to this episode from Society for Reproductive Investigation on Spotify. On this episode of Reproductive Sciences, host Dr. Shangaris welcomes Elizabeth Levit, Bhuchitra Singh, Elisabeth Nylander and James H. Segars, authors of a recently published Endocrinology review titled "A Systematic Rev...

09/22/2023

New study in Reproductive Sciences identifies placental diseases as the likely cause for 99% of unexplained pregnancy losses, shedding light on miscarriages and stillbirths. The research suggests that identifying specific placental pathologies could lead to more preventative measures.

07/31/2023

07/31/2023

Insights Unveiled: Discovering the SRI Community's Awareness about the Reproductive Sciences Journal - A Special VodCast from the 2023 SRI Conference

07/07/2023

Just published a fascinating podcast discussing the role of T cells in maternal immune tolerance during pregnancy. Researchers analyzed uterine intervillous blood and found differences in T cell phenotype and function in preeclampsia cases. Impaired immune tolerance and a pro-inflammatory microenvironment were observed. Exciting insights for potential immunotherapeutic strategies! 🤰🔬

https://open.spotify.com/episode/2tJxKWr1XXH6oB2pGgr2n2?si=CyVxzme1SLK0yhZSHwRpXw

Listen to this episode from Society for Reproductive Investigation on Spotify. On this episode, Panicos Shangaris interviews Professor Ai-ris Y. Collier from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston on her paper "Altered Cytokine Production in Human Intervillous...

03/24/2023

In discussion with the chief and associate editors on how to get published at the

03/22/2023

A great editorial luncheon at the with the ReproSciences Team and Chief, co-Editor, Professor Gregory Christman, giving us an update on the latest metrics.